Regeneron Pharmaceuticals (REGN)
EBITDA Margin
38.75%
Quarterly · Period ending:
REGN EBITDA Margin
Latest reported38.75%period ending
Latest reported38.75%period ending
REGN Quarterly EBITDA Margin (100.00% → 38.75%)
Quarterly ebitda margin
High-resolution chart · PNG
REGN ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -288.389% | |
| -147.2977% | |
| -42.3053% | |
| -96.1559% | |
| -19.6251% | |
| -71.9566% | |
| 1.6807% | |
| -37.1681% | |
| -127.1186% | |
| -176.3636% | |
| -74.3243% | |
| -15.7407% | |
| 11.1111% | |
| -61.5385% | |
| 20.1754% | |
| -1.1236% | |
| -37.8788% | |
| -46.7742% | |
| -44.6154% | |
| -46.7742% | |
| -35.4839% | |
| -61.5385% | |
| -24.1379% | |
| -12.9032% | |
| 2.6316% | |
| -7.2464% | |
| -50.6494% | |
| -29.2135% | |
| -250% | |
| -316.6667% | |
| -355.1724% | |
| -236.1111% | |
| -700% | |
| -404.7619% | |
| -239.1304% | |
| -212.5% | |
| -93.75% | |
| -80% | |
| -170% | |
| -121.0526% | |
| -105.8824% | |
| 100% | |
| -538.4615% | |
| 100% | |
| 100% | |
| 100% |